Corrigendum to ‘Mast cell activation test in chlorhexidine allergy: a proof of concept’ (Br J Anaesth 2020; 125: 970–5) (British Journal of Anaesthesia (2020) 125(6) (970–975), (S0007091220304827), (10.1016/j.bja.2020.06.024))

Jessy Elst, Marie Line M. van der Poorten, Margaretha A. Faber, Athina L. Van Gasse, Lene H. Garvey, Chris H. Bridts, Leander P. De Puysseleyr, Christel Mertens, Margo M. Hagendorens, Vito Sabato, Didier G. Ebo*

*Corresponding author af dette arbejde

Abstract

The authors regret that errors were present in the above article. The end concentrations of chlorhexidine should be 0.0025, 0.25, 25 and 2 500 ng mL−1. The corrected figure 2 is present below: [Figure presented] The corrected legend of figure 3 is also present below: Fig 3. Representative plots of mast cell activation tests with chlorhexidine. Cultured human mast cells were activated with chlorhexidine (2 500 ng ml−1) after passive sensitisation of the cells with serum of a patient with positive skin test and basophil activation test (ST+BAT+), or a patient with negative skin test and basophil activation test (ST–BAT–). The authors would like to apologise for any inconvenience caused.

OriginalsprogEngelsk
TidsskriftBritish Journal of Anaesthesia
Vol/bind126
Udgave nummer3
Sider (fra-til)748-749
Antal sider2
ISSN0007-0912
DOI
StatusUdgivet - mar. 2021

Fingeraftryk

Dyk ned i forskningsemnerne om 'Corrigendum to ‘Mast cell activation test in chlorhexidine allergy: a proof of concept’ (Br J Anaesth 2020; 125: 970–5) (British Journal of Anaesthesia (2020) 125(6) (970–975), (S0007091220304827), (10.1016/j.bja.2020.06.024))'. Sammen danner de et unikt fingeraftryk.

Citationsformater